G
OCGN icon

Gainplan’s Ocugen OCGN Stock Holding History

Gainplan’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,325
Closed -$18.5K – 71
2025
Q3 		$18.5K Sell
11,325
-764
-6% -$847 0.01% 61
2025
Q2 		$11.7K Buy
12,089
+1,000
+9% +$829 0.01% 54
2025
Q1 		$7.83K Sell
11,089
-11,611
-51% -$8.03K 0.01% 47
2024
Q4 		$18.3K Sell
22,700
-923
-4% -$845 0.01% 54
2024
Q3 		$36.6K Hold
23,623
– – 0.02% 57
2024
Q2 		$36.6K Buy
23,623
+9,663
+69% +$15.1K 0.02% 56
2024
Q1 		$22.9K Buy
+13,960
New +$11.7K 0.01% 67

Other funds holding OCGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Gainplan's OCGN Position: Q4 2025 in Review

Gainplan sold out of Ocugen (OCGN) in Q4 2025, closing a stake of 11,325 shares — an estimated $18.5K sold.

Gainplan first reported a position in OCGN in Q1 2024 and held it in 7 quarters. The position peaked at $36.6K in Q3 2024. 109 funds tracked by Wall St. Rank hold OCGN as of Q4 2025.

  • Gainplan reported no remaining Ocugen position as of Q4 2025 after selling out during the quarter.
  • Gainplan sold 11,325 Ocugen shares in Q4 2025, an estimated $18.5K.
  • Gainplan first reported a position in Ocugen in Q1 2024 and held it in 7 quarters.
  • Gainplan's Ocugen position peaked at $36.6K in Q3 2024.
  • 109 funds tracked by Wall St. Rank held Ocugen as of Q4 2025.

Based on Gainplan's 13F filing for Q4 2025, filed 23 Jan 2026.